Akèy › Estesioneuroblastom Olfaktif
Etid klinik pou Estesioneuroblastom Olfaktif ap rekrite nan Etazini
6 etid pou Estesioneuroblastom Olfaktif ap rekrite patisipan nan sit atravè Etazini.
Vil ki gen plis etid
Pa eta
Etid ki fèk mete ajou
Tèks ofisyèl etid la (Anglè)
[212Pb]VMT-Alpha-NET in Metastatic or Inoperable Somatostatin-Receptor Positive Gastrointestinal Neuroendocrine Tumors, Pheochromocytoma/Paragangliomas, Small Cell Lung, Renal Cell, and Head and Neck Cancers
Ap rekriteFaz 1
Laj 18 a 120 · Tout sèks · Mizajou Sep 29, 2026 · NCT06479811Radiation Combined With BIspecific T-Cell Engager in DLL3 Expressing Tumors
Ap rekriteFaz 1/2
Laj 18 a 99 · Tout sèks · Mizajou Sep 22, 2026 · NCT06814496Enasidenib in IDH2-Mutated Malignant Sinonasal and Skull Base Tumors
Ap rekriteFaz 2
Laj 18 a 120 · Tout sèks · Mizajou Sep 21, 2026 · NCT06176989A Natural History Study of Children and Adults With Olfactory Neuroblastoma
Ap rekriteEtid obsèvasyon
Laj 3 a 120 · Tout sèks · Mizajou Aug 17, 2026 · NCT0475520568-Ga DOTATATE PET/MRI in the Diagnosis and Management of Somatostatin Receptor Positive CNS Tumors.
Ap rekriteFaz 4
Laj 18 a 100 · Tout sèks · Mizajou Nov 21, 2025 · NCT04081701Tissue Sample Collection From Patients With Head and Neck Cancer and From Healthy Participants
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 18 ak plis · Tout sèks · Mizajou Oct 28, 2025 · NCT00898638Sous ClinicalTrials.gov, done yo ranmase Oct 1, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.